ORASURE TECHNOLOGIES, INC Debt Securities, Available-for-sale, Current
ORASURE TECHNOLOGIES, INC (OSUR) had Debt Securities, Available-for-sale, Current of $9.14 million as of 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2024-08-06
- 2024-06-30: Debt Securities, Available-for-sale, Current $9.14M.
- 2024-03-31: Debt Securities, Available-for-sale, Current $16.63M.
- 2023-09-30: Debt Securities, Available-for-sale, Current $7.36M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2024-06-30 | $9.14M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $16.63M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $7.36M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |